These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 11796840

  • 1. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P, Sanderson RD, Fan CY, Smoller BR.
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [Abstract] [Full Text] [Related]

  • 2. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
    Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Takamori K, Igawa K, Yoshida M, Fukuyama H, Takahashi T, Sakoda S.
    J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
    [Abstract] [Full Text] [Related]

  • 3. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P, Liu K, Hanna EY, Suen JY, Fan CY.
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [Abstract] [Full Text] [Related]

  • 4. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
    Rintala M, Inki P, Klemi P, Jalkanen M, Grénman S.
    Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
    [Abstract] [Full Text] [Related]

  • 5. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D, Boricic I, Todorovic V, Tomanovic N, Radojevic S.
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [Abstract] [Full Text] [Related]

  • 6. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T, Zamolo G, Coklo M, Hadzisejdic I, Stemberger C, Zauhar G.
    Pathol Res Pract; 2006 Dec; 202(8):599-607. PubMed ID: 16781827
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S, Josef J.
    Anticancer Res; 2002 Dec; 22(5):3019-23. PubMed ID: 12530035
    [Abstract] [Full Text] [Related]

  • 9. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D, Turkmenoglu TT, Kabukcuoglu F.
    Pathol Res Pract; 2009 Dec; 205(9):589-94. PubMed ID: 19577853
    [Abstract] [Full Text] [Related]

  • 10. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
    Tan KB, Lee YS.
    Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
    [Abstract] [Full Text] [Related]

  • 11. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA, Ross JS, Sheehan CE, Carlson JA.
    Mod Pathol; 2000 Apr; 13(4):427-32. PubMed ID: 10786810
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E, Ioachim E, Briasoulis E, Charchanti A, Damala K, Karavasilis V, Pavlidis N, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [Abstract] [Full Text] [Related]

  • 13. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
    Kerschmann RL, McCalmont TH, LeBoit PE.
    Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
    [Abstract] [Full Text] [Related]

  • 14. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma.
    Bayer-Garner IB, Sanderson RD, Smoller BR.
    J Cutan Pathol; 1999 Sep; 26(8):386-90. PubMed ID: 10551410
    [Abstract] [Full Text] [Related]

  • 15. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue.
    Ro Y, Muramatsu T, Shima K, Yajima Y, Shibahara T, Noma H, Shimono M.
    Int J Oral Maxillofac Surg; 2006 Mar; 35(3):252-7. PubMed ID: 16280239
    [Abstract] [Full Text] [Related]

  • 16. Syndecan-1 expression has prognostic significance in head and neck carcinoma.
    Anttonen A, Kajanti M, Heikkilä P, Jalkanen M, Joensuu H.
    Br J Cancer; 1999 Feb; 79(3-4):558-64. PubMed ID: 10027330
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL, Garrod DR, Madani S, Buchanan MD, Clark RE.
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [Abstract] [Full Text] [Related]

  • 18. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.
    Bayer-Garner IB, Smoller BR.
    J Cutan Pathol; 2001 Feb; 28(2):83-9. PubMed ID: 11168756
    [Abstract] [Full Text] [Related]

  • 19. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T, Zamolo G, Brumini G, Biljan D, Petranović D, Troselj-Vukić B.
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [Abstract] [Full Text] [Related]

  • 20. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R, Martínez-Barba E, López-Poveda MJ, Vidal-Abarca Gutiérrez I, Ruíz-Maciá JA, Oviedo-Ramirez I, Martínez-Menchón T.
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.